Cargando…
Challenges and Prospects of Plant-Derived Oral Vaccines against Hepatitis B and C Viruses
Hepatitis B and C viruses chronically affect approximately 3.5% of the global population, causing more than 800,000 deaths yearly due to severe liver pathogenesis. Current HBV vaccines have significantly contributed to the reduction of chronic HBV infections, supporting the notion that virus eradica...
Autores principales: | Pantazica, Ana-Maria Madalina, Cucos, Lia-Maria, Stavaru, Crina, Clarke, Jihong-Liu, Branza-Nichita, Norica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537828/ https://www.ncbi.nlm.nih.gov/pubmed/34685844 http://dx.doi.org/10.3390/plants10102037 |
Ejemplares similares
-
Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1(16-42) antigen
por: Pantazica, Ana-Maria, et al.
Publicado: (2022) -
The “humanized” N‐glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus‐neutralizing antibody response in vaccinated mice
por: Pantazica, Ana‐Maria, et al.
Publicado: (2023) -
Probing the Hepatitis B Virus E-Antigen with a Nanopore Sensor Based on Collisional Events Analysis
por: Bucataru, Ioana C., et al.
Publicado: (2022) -
Plant-made vaccines against viral diseases in humans and farm animals
por: Su, Hang, et al.
Publicado: (2023) -
Modulation of the unfolded protein response by the human hepatitis B virus
por: Lazar, Catalin, et al.
Publicado: (2014)